Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-05-30 00:00:00 ET · period of report 2023-05-25 · accession 0000950170-23-024875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-30 | 2023-05-25 | TMDX | Lovell Stephanie | Dir | A - Grant | $0.00 | +1,193 | 1,193 | New | $0 |
| D | 2023-05-30 | 2023-05-25 | TMDX | Lovell Stephanie | Dir | A - Grant | $0.00 | +1,916 | 1,916 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-25 | A | A | 1,193 | $0.00 | 1,193 | D | — | — | (F1) Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-25 | A | A | 1,916 | $0.00 | 1,916 | D | $71.33 · — to 2033-05-25 | 1,916 Common Stock | (F2) The option vests in full on the earlier of May 25, 2024 or the date of the 2024 annual meeting of the stockholders of the Issuer, subject to continued service. |